Healthcare system effects of pay-for-performance for smoking status documentation
- PMID: 23919419
- PMCID: PMC3874815
Healthcare system effects of pay-for-performance for smoking status documentation
Abstract
Objectives: To evaluate the impact on smoking status documentation of a payer-sponsored pay-for-performance (P4P) incentive that targeted a minority of an integrated healthcare delivery system's patients.
Study design: Three commercial insurers simultaneously adopted P4P incentives to document smoking status of their members with 3 chronic diseases. The healthcare system responded by adding a smoking status reminder to all patients' electronic health records (EHRs). We measured change in smoking status documentation before (2008-2009) and after (2010-2011) P4P implementation by patient P4P eligibility.
Methods: The P4P-eligible patients were compared primarily with a subset of non-P4P-eligible patients who resembled P4P-eligible patients and also with all non-P4P-eligible patients. Multivariate models adjusted for patient and provider characteristics and accounted for provider-level clustering and preimplementation trends.
Results: Documentation increased from 48% of 207,471 patients before P4P to 71% of 227,574 patients after P4P. Improvement from 56% to 83% occurred among P4P-eligible patients (adjusted odds ratio [AOR], 3.6; 95% confidence interval [CI], 2.9-4.5) and from 56% to 80% among the comparable subset of non-P4P-eligible patients (AOR, 3.0; 95% CI, 2.3-3.9). The difference in improvement between groups was significant (AOR, 1.3; 95% CI, 1.1-1.4; P = .009).
Conclusions: A P4P incentive targeting a minority of a healthcare system's patients stimulated adoption of a system wide EHR reminder and improved smoking status documentation overall. Combining a P4P incentive with an EHR reminder might help healthcare systems improve treatment delivery for smokers and meet "meaningful use" standards for EHRs.
Conflict of interest statement
Financial Disclosures and Potential Conflicts of Interest: GRK none. YC none. JHHK none. JAL none. JE none. NAR unpaid consultancy for Pfizer and Alere Wellbeing, research grants to Massachusetts General Hospital from Nabi Biopharmaceuticals, and royalties from UpToDate.
Figures


References
-
- Fiore MC, Jaen CR, Baker T, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services; 2008.
-
- Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291(10):1238–1245. - PubMed
-
- Jamal A, Dube SR, Malarcher AM, Shaw L, Engstrom MC Office on Smoking and Health National Center for Chronic Disease Prevention and Health Promotion. Tobacco use screening and counseling during physician office visits among adults - national ambulatory medical care survey and national health interview survey, United States, 2005–2009. MMWR Surveill Summ. 2012 Jun;61(2):38–45. - PubMed
-
- Blumenthal D, Tavenner M. The"meaningful use" regulation for electronic health records. N Engl J Med. 2010 Aug;363(6):501–504. - PubMed
-
- Joseph AM, Arikian NJ, An LC, et al. Results of a randomized controlled trial of intervention to implement smoking guidelines in Veterans Affairs medical centers: increased use of medications without cessation benefit. Med Care. 2004 Nov;42(11):1100–1110. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical